Results 111 to 120 of about 25,145 (199)

Cost‐Effectiveness of an Antibacterial Envelope in Patients at High Risk of Cardiac Implantable Electronic Device Infection in the Australian Public Healthcare System

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
Use of an antibacterial envelope in patients at high risk of infection implanted with a cardiac implantable electronic device results in a reduction in infection and an increased quality of life. The incremental cost‐effectiveness ratio is dominant (increases quality of life without increasing cost).
Michelle Hill, Behnoosh Hosseinloui Khalaj, Md Shajedur Rahman Shawon, Liesl Strachan, Gabrielle Challis, Kate King, Louisa Jorm, Reece Holbrook   +7 more
wiley   +1 more source

Extravascular implantable cardioverter-defibrillator implantation in a teenager with Brugada syndrome and recurrent inappropriate shocks of subcutaneous implantable cardioverter-defibrillator. [PDF]

HeartRhythm Case Rep
Garibaldi S, Aimo A, Concistrè G, Nesti M, Panchetti L, Startari U, Mirizzi G, Santoro G, Piacenti M, Rossi A.   +9 more
europepmc   +1 more source

Implantable Cardioverter-Defibrillators [PDF]

JAMA, 2006
Janet M. Torpy, Cassio Lynm, Richard M. Glass   +2 more
openaire   +2 more sources

Annual Trends and Regional Disparities in Transvenous Lead Extractions in Japan: Insights From the Nationwide Japanese Registry of All Cardiac and Vascular Diseases‐Diagnostic Procedure Combination Data

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
This nationwide analysis of 3573 transvenous lead extraction (TLE) procedures from 108 certified hospitals demonstrated a steady rise in TLEs, driven by increasing non‐infectious indications. Also, TLE use varied across regions, indicating persistent geographic disparities. ABSTRACT Background The increasing use of cardiovascular implantable electronic
Toshihiro Nakamura, Koji Fukuzawa, Yoko Sumita, Koshiro Kanaoka, Kimitake Imamura, Mitsuru Takami, Hiromasa Otake   +6 more
wiley   +1 more source

Benefits of Implantable Cardioverter-Defibrillator for Secondary Prevention in Patients With Organic Heart Disease. [PDF]

Ann Noninvasive Electrocardiol
Akagawa R, Otsuki S, Sakurazawa M, Kato A, Furuse H, Suzuki N, Ikami Y, Hasegawa Y, Chinushi M, Inomata T.   +9 more
europepmc   +1 more source

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 935-945, February 2026.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang, Pauline Reynier, Antonios Douros, Oriana H. Y. Yu, Robert W. Platt, Kristian B. Filion   +5 more
wiley   +1 more source

Is Septal Pacing Effective for Antitachycardia Pacing of Implantable Cardioverter-Defibrillator? [PDF]

JACC Asia
Ishibashi K, Ueda N, Kusano K.
europepmc   +1 more source

Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

Pacing and Clinical Electrophysiology, Volume 49, Issue 2, Page 71-81, February 2026.
ABSTRACT Background Implantable cardioverter defibrillator (ICD) therapy can prevent sudden cardiac death, but poses a risk of inappropriate device therapy (IDT), which is linked to worse outcomes and reduced quality of life. On the other hand, ICDs can function as an early warning system for atrial arrhythmias.
Marthe J. Huntelaar, Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Mischa T. Rijnierse, Michiel J. B. Kemme, Cornelis P. Allaart, Vokko P. van Halm   +6 more
wiley   +1 more source

Echocardiographic Predictors of Ventricular Arrhythmias Post-Automatic Implantable Cardioverter-Defibrillator Implantation. [PDF]

J Cardiovasc Dev Dis
Harapoz M, Zochowski YSA, Trivedi SJ, Kumar S, Thomas L.   +4 more
europepmc   +1 more source

Exercise-guided programming of a subcutaneous implantable cardioverter-defibrillator in an athlete. [PDF]

HeartRhythm Case Rep
Hsieh PN, Kontopidis A, Burr J, Stewart K, Churchill TW, Guseh JS, Chung EH.   +6 more
europepmc   +1 more source